Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Evaluate the persistence and immune memory induced by a primary vaccination course with GSK Biologicals’ MenC-TT (1 formulation) & GSK Biologicals’ Hib-MenC-TT (2 formulations) or Meningitec™ in healthy toddlers aged 12-15 mths primed in study 711202/001
Meningococcal Vaccine
711202/008
NCT00135564
Infections, Meningococcal
Phase 2
 
This is a persistence study of 711202/001. An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015

Powered by ideaPoint, Inc.